Home/Pipeline/Freespira for Adolescents

Freespira for Adolescents

Panic & Anxiety Symptoms in Adolescents (13+)

ApprovedActive

Key Facts

Indication
Panic & Anxiety Symptoms in Adolescents (13+)
Phase
Approved
Status
Active
Company

About Freespira

Freespira is a commercial-stage digital therapeutics company offering a non-medication, device-based treatment for panic attacks and PTSD. Its FDA-cleared system addresses physiological dysregulation linked to these conditions by training users to normalize their breathing and CO2 sensitivity. The company has demonstrated strong clinical results, including high rates of patients remaining panic attack-free one year post-treatment, and is now expanding its reach to adolescents. Its business model focuses on B2B partnerships with payers and providers to drive adoption.

View full company profile

Therapeutic Areas